Suppr超能文献

比较迷幻和濒死或其他非寻常体验对死亡和临终态度的改变。

Comparison of psychedelic and near-death or other non-ordinary experiences in changing attitudes about death and dying.

机构信息

Department of Psychiatry and Behavioral Sciences, Behavioral Pharmacology Research Unit, Center for Psychedelics and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

Department of Neurosciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, United States of America.

出版信息

PLoS One. 2022 Aug 24;17(8):e0271926. doi: 10.1371/journal.pone.0271926. eCollection 2022.

Abstract

Both psychedelic drug experiences and near-death experiences can occasion changes in perspectives on death and dying, but there have been few direct comparisons of these phenomena. This study directly compared psychedelic occasioned and non-drug experiences which altered individuals' beliefs about death. Individuals who reported an experience that altered their beliefs about death occasioned by either a psychedelic drug or a near-death or other non-ordinary experience completed an online survey. Circumstances of the experience, mystical and near-death subjective features, changes in attitudes about death, and other persisting effects were evaluated. The study sample (n = 3192) included five groups: non-drug near-death or other non-ordinary experiences (n = 933), and drug experiences occasioned by lysergic acid diethylamide (LSD) (n = 904), psilocybin (n = 766), ayahuasca (n = 282), or N,N-dimethyltryptamine (DMT) (n = 307). Analyses of differences in experiences were adjusted statistically for demographic differences between groups. Compared to the psychedelic groups, the non-drug group was more likely to report being unconscious, clinically dead, and that their life was in imminent danger. The groups were remarkably similar in the reported changes in death attitudes attributed to the experience, including a reduced fear of death and high ratings of positive persisting effects and personal meaning, spiritual significance, and psychological insight. Although both psychedelic and non-drug participants showed robust increases on standardized measures of mystical and near-death experiences, these measures were significantly greater in the psychedelic participants. Non-drug participants were more likely to rate their experiences as the single most meaningful of their lives. Comparing across psychedelic substances, ayahuasca and DMT groups tended report stronger and more positive enduring consequences of the experience than the psilocybin and LSD groups, which were largely indistinguishable. These data provide a detailed characterization and comparison of psychedelic occasioned and non-drug experiences that changed attitudes about death and suggest the importance of future prospective psychedelic administration studies.

摘要

迷幻药物体验和濒死体验都可能改变人们对死亡和临终的看法,但对这些现象的直接比较很少。本研究直接比较了迷幻药物体验和非药物体验,这些体验改变了个体对死亡的信念。报告了因迷幻药物或濒死或其他非寻常体验而改变对死亡信念的个体,通过在线调查完成了一项调查。评估了体验的情况、神秘和濒死主观特征、对死亡态度的变化以及其他持续影响。研究样本(n = 3192)包括五个组:非药物濒死或其他非寻常体验(n = 933),和由麦角酸二乙酰胺(LSD)(n = 904)、裸盖菇素(n = 766)、阿育吠陀(n = 282)或 N,N-二甲基色胺(DMT)(n = 307)引起的药物体验。对体验差异的分析在统计学上调整了组间的人口统计学差异。与迷幻药物组相比,非药物组更有可能报告无意识、临床死亡和生命处于迫在眉睫的危险之中。报告归因于体验的死亡态度变化方面,各组非常相似,包括减少对死亡的恐惧以及高度评价积极的持续影响以及个人意义、精神意义和心理洞察力。尽管迷幻药物和非药物组参与者在标准化的神秘和濒死体验测量中都表现出了显著的增加,但迷幻药物组的参与者增加幅度更大。非药物组更有可能将其体验评为一生中最有意义的体验。比较迷幻药物物质,阿育吠陀和 DMT 组倾向于报告体验的强烈和更积极的持久后果,比裸盖菇素和 LSD 组更强,后者基本没有区别。这些数据提供了对改变死亡态度的迷幻药物体验和非药物体验的详细描述和比较,并表明未来前瞻性迷幻药物给药研究的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6562/9401141/46e93f1091f5/pone.0271926.g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验